tiprankstipranks
Cara Therapeutics (CARA)
NASDAQ:CARA
US Market

Cara Therapeutics (CARA) Technical Analysis

Compare
2,283 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
3Neutral
5Bearish
Technical Analysis Consensus
Sell
3Bullish
3Neutral
4Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Cara Therapeutics’s (CARA) Moving Averages Convergence Divergence (MACD) indicator is 0.01, suggesting Cara Therapeutics is a Sell.
Cara Therapeutics’s (CARA) 20-Day exponential moving average is 4.93, while Cara Therapeutics’s (CARA) share price is $5.06, making it a Buy.
Cara Therapeutics’s (CARA) 50-Day exponential moving average is 4.80, while Cara Therapeutics’s (CARA) share price is $5.06, making it a Buy.

Cara Therapeutics (CARA) Pivot Points

Mar 14, 2025, 01:58 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.79
4.89
5.00
5.10
5.21
5.31
5.42
Fibonacci
4.89
4.97
5.02
5.10
5.18
5.23
5.31
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cara Therapeutics (CARA) Moving Averages

Mar 14, 2025, 01:58 PM
Period
Simple
Exponential
MA5
5.02Buy
5.01Buy
MA10
4.83Buy
4.94Buy
MA20
4.96Buy
4.93Buy
MA50
4.97Buy
4.80Buy
MA100
4.32Buy
4.67Buy
MA200
4.31Buy
5.24Sell
Cara Therapeutics’s (CARA) 10-Day exponential moving average is 4.94, while Cara Therapeutics’s (CARA) share price is $5.06, making it a Buy.
Cara Therapeutics’s (CARA) 100-Day exponential moving average is 4.67, while Cara Therapeutics’s (CARA) share price is $5.06, making it a Buy.
Cara Therapeutics’s (CARA) stock price is $5.06 and Cara Therapeutics’s (CARA) 50-day simple moving average is 4.97, creating a Buy signal.
Cara Therapeutics’s (CARA) stock price is $5.06 and Cara Therapeutics’s (CARA) 100-day simple moving average is 4.32, creating a Buy signal.
Cara Therapeutics’s (CARA) stock price is $5.06 and Cara Therapeutics’s (CARA) 200-day simple moving average is 4.31, creating a Buy signal.

Cara Therapeutics (CARA) Technical Indicators

Mar 14, 2025, 01:58 PM
Name
Value
Implied Action
RSI (14)
53.97
Neutral
STOCH (9,6)
88.43
Sell
STOCHRSI (14)
88.43
Sell
MACD (12,26)
0.01
Sell
ADX (14)
14.98
Buy
Williams %R
-15.84
Sell
CCI (14)
46.73
Neutral
ATR (14)
0.30
-
Ultimate Oscillator
61.78
Neutral
ROC
1.81
Buy
Cara Therapeutics’s (CARA) Relative Strength Index (RSI) is 53.97, creating a Neutral signal.
Cara Therapeutics’s (CARA) Trend Strength Indicator (ADX) is 14.98, creating a Buy signal.
Cara Therapeutics’s (CARA) Commodity Channel Index (CCI) is 46.73, creating a Neutral signal.
Cara Therapeutics’s (CARA) Price Rate of Change (ROC) is 1.81, creating a Buy signal.

FAQ

Is CARA a Buy, Hold, or Sell?
Based on CARA’s technical indicators, CARA is a Buy.
    What is CARA’s RSI (14)?
    CARA’s RSI (14) is 53.97, which suggests CARA is a Neutral.
      What is CARA’s MACD?
      CARA’s MACD is 0.01, which suggests CARA is a Sell.
        What is CARA’s 5-day moving average?
        CARA’s 5-day moving average is 5.02, which suggests CARA is a Buy.
          What is CARA’s 20-day moving average?
          CARA 20-day moving average is 4.96, which suggests CARA is a Buy.
            What is CARA’s 50-day moving average?
            CARA’s 50-day moving average is 4.97, which suggests CARA is a Buy.
              What is CARA’s 200-day moving average?
              CARA’s 200-day moving average is 4.31, which suggests CARA is a Buy.
                What is CARA’s Williams % R (14)?
                CARA’s Williams % R (14) is -15.84, which suggests CARA is a Sell.
                  What is CARA’s CCI (14)?
                  CARA’s CCI (14) is 46.73, which suggests CARA is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis